Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER

Adenocarcinoma of Ovary

CanariaBio Inc.monoclonal_antibodyPhase 2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Adenocarcinoma of Ovary cohort.

Asset / SponsorPhaseRating
IERAMILIMAB
Novartis Pharmaceuticals
Phase 2B
Cyclophosphamide
TCR2 Therapeutics
Phase 1/2CCC
Niraparib
CanariaBio Inc.
Phase 2CCC
Nivolumab
National Cancer Institute (NCI)
Phase 2CCC
Ipilimumab
National Cancer Institute (NCI)
Phase 2CCC

View all 15 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER is also rated in:

peritoneal carcinomaDormant
B
Indicative ·
56 / 100
View asset →
ovarian neoplasmDormant
B
Indicative ·
56 / 100
View asset →
ovarian serous adenocarcinomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →